Controlled absorption of statins in the intestine

Details for Australian Patent Application No. 2005305459 (hide)

Owner Dexcel Pharma Technologies Ltd.

Inventors Penhasi, Adel

Agent Freehills

Pub. Number AU-A-2005305459

PCT Pub. Number WO2006/054307

Priority 60/629,336 22.11.04 US

Filing date 22 November 2005

Wipo publication date 26 May 2006

International Classifications

A61K 31/401 (2006.01) - Proline

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/054307 Priority application(s): WO2006/054307

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305460-Stable atorvastatin formulations

2005305456-Use of lipid conjugates in the treatment of disease